VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1661829
Sex: F
Age:
State: MO

Vax Date: 04/17/2021
Onset Date: 04/23/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: Pregnancy Test; Result Unstructured Data: Test Result:taken 4 pregnancy tests, all negative.

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Menstrual cycle is late; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 17Apr2021 at 12:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included vitamins (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the right arm on 27Mar2021 at 13:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021, the patient experienced menstrual cycle was late. Had taken 4 pregnancy tests, all negative. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date in 2021, the patient underwent Pregnancy Test and the result was negative. Patient stated to have undergone four pregnancy tests, all of them were negative. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle was late. Had taken 4 pregnancy tests, all negative was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661830
Sex: F
Age:
State: OH

Vax Date: 04/12/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210422; Test Name: SARS-COV-2 PCR Saliva Surveillance; Test Result: Negative

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Left armpit got swollen; Pain radiates to elbow and can't use arm; Left armpit got swollen and it started to ache.; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 12Apr2021 at 17:15 (at the age of 25-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included hyoscine butylbromide (BUSCOPAN), minocycline capsule (MANUFACTURER UNKNOWN) and tretinoin gel (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. On 24Apr2021 at 15:00, 12 days after vaccination, the patient experienced left armpit got swollen and it started to ache, the pain radiates to elbow and can't use her arm. On 22Apr2021, the patient underwent SARS-CoV-2 PCR saliva surveillance and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events left armpit got swollen and it started to ache, the pain radiates to elbow and can't use arm were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: BUSCOPAN; MINOCYCLINE; TRETINOIN

Current Illness:

ID: 1661831
Sex: F
Age:
State: MI

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Tingling/pins and needles feeling in both hands and arms; Lightheadedness when standing up; Feeling spaced out; Unable to sleep first night after vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the arm right on 24Apr2021 at 08:30 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included Henoch-Schonlein Purpura, anxiety, depression and ADHD (Attention deficit Hyperactive Disorder) and allergy to sulfa drugs (sulfonamide allergy). Concomitant medications included ursodeoxycholic acid (ACTIGALL), omeprazole (PRILOSEC), famotidine (PEPCID), melatonin (MANUFACTURER UNKNOWN) and amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) for unknown indication from an unknown date. The patient previously took diphenhydramine; paracetamol; phenylpropanolamine hydrochloride (BENADRYL) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8733) in the left arm on 27Mar2021 at 11:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr 2021, first night after the vaccine the patient was unable to sleep. On 25Apr2021 at 11:00, the patient experienced Tingling/ pins and needles feeling in both hands and arms, light-headedness when standing up and feeling spaced out. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling/ pins and needles feeling in both hands and arms, light-headedness when standing up, feeling spaced out and unable to sleep first night after the vaccine were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ACTIGALL; PRILOSEC [OMEPRAZOLE]; FAMOTIDINE; MELATONIN; ADDERALL

Current Illness:

ID: 1661832
Sex: M
Age:
State: MA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Headache; Skin was warm to touch; Chills; Difficulty sleeping; This is a spontaneous report from a contactable consumer. A 37-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via intramuscular route of administration on 14Apr2021 at 11:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis and colectomy. It was unknown if the patient had allergies to medications, food or other products. The patient received unspecified antibiotics within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 16:00, the patient experienced headache, skin was warm to touch, chills and had difficulty sleeping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, skin was warm to touch, chills and difficulty sleeping were resolved the day following vaccination, on 15Apr2021 by 08:00. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661833
Sex: F
Age:
State: GA

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Muscle soreness; Very tired; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0165) via an unspecified route of administration in the arm left on 24Apr2021 at 15:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to strawberries and latex. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on 03Apr2021 at 16:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation.The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Apr2021 at 20:00, the patient experienced being very tired, nausea and muscle soreness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any treatment for the events. The clinical outcome of the events very tired, nausea and muscle soreness were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661834
Sex: M
Age:
State: TX

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Left ear had mild tinnitus and now started experiencing very loud tinnitus on left ear; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: en9581) via an unspecified route of administration in the left arm on 24Apr2021 at 15:30 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included tinnitus; left ear had mild tinnitus. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included prednisone (MANUFACTURER UNKNOWN) from an unknown date for unspecified indication. On 25Apr2021 at 06:00, the patient experienced left ear had mild tinnitus and now started experiencing very loud tinnitus on left ear after day 1 of vaccine. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event left ear had mild tinnitus and now started experiencing very loud tinnitus on left ear was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PREDNISONE

Current Illness:

ID: 1661835
Sex: F
Age:
State: MA

Vax Date: 03/12/2021
Onset Date: 04/12/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: 5 weeks after the second shot I have pain in my arm from the shot area down to my hand.; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 75-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy (sulfur). The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Feb2021 at 14:30 (at the age of 75-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021 at 08:00, five weeks after the second shot, the patient experienced pain in arm from the shot area down to hand. This has been going on for one week. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of adverse event which included treatment with Aspirin (which helped only somewhat). The clinical outcome of the event pain in arm from the shot area down to hand was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661836
Sex: M
Age:
State: MO

Vax Date: 04/10/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Occasional moderate dizziness; Occasional moderatedizziness/vertigo; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 10Apr2021 at 14:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included esomeprazole (NEXIUM), loratadine (CLARITIN), magnesium (MANUFACTURER UNKNOWN), cherry extract (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIR) from unknown start dates for unknown indications. In Apr2021, the patient experienced occasional moderate dizziness/vertigo. Since the vaccination, the patient had not been tested for COVID-19. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcomes of the event occasional moderate dizziness/vertigo was unknown at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: ESOMEPRAZOLE; LORATADINE; MAGNESIUM; ACETYLSALICYLIC ACID

Current Illness:

ID: 1661837
Sex: M
Age:
State: TX

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Mild dizziness developed two days post injection.; When moving from vertical to horizontal or vise versa I would get a dizzy feeling and loose balance.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration in the arm left on 31Mar2021 at 13:45 (at the age of 30-year-old) as a single dose for COVID-19 immunisation. The medical history included asthma and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 02Apr2021 at 04:00, the patient experienced mild dizziness and loose balance. It was reported that when moving from vertical to horizontal or vise versa the patient would get a dizzy feeling and loose balance. An example was getting out of bed after sleep, he would have to wait for the body to adjust to vertical orientation and dizziness to subside before taking steps. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild dizziness and loose balance were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661838
Sex: F
Age:
State: NY

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Ocular migraine headaches; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 17Mar2021 at 11:15 (at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included thyroid issue, blood pressure high (HBP), high cholesterol and high sugar. The patient had known seasonal/yearly allergies, allergy to dust, dust mites and pollen. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), omeprazole (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), alprazolam (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and atorvastatin calcium (LIPITOR), all for unknown indications from an unknown date and unknown if ongoing. On 17Mar2021 at 20:00, the patient experienced ocular migraine headaches. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event ocular migraine headache was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID; OMEPRAZOLE; METFORMIN; ALPRAZOLAM; AMLODIPINE; LIPITOR

Current Illness:

ID: 1661839
Sex: F
Age:
State: GA

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Pain in arm similar to tetanus shot; Slight headache off and on for a day; Slight fatigue; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Apr2021 at 13:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to soy milk. The patient previously took amoxicillin on an unknown date for unknown indication and experienced drug allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:30 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. On 25Apr2021 at 00:00, the patient experienced pain in arm similar to tetanus shot, slight headache off and on for a day and slight fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in arm, headache and fatigue were recovered on 25Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1661840
Sex: F
Age:
State: WA

Vax Date: 04/22/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Fatigue; Body aches; Flu like symptoms; This is a spontaneous report from a contactable consumer. A 73-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on 22Apr2021 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration on an unknown date in Apr2021 (at the age of 73-years-old), as a single dose for COVID-19 immunisation. On 24Apr2021, the patient experienced fatigue, body aches, flu like symptoms after second dose lasting two days and unknown if fever occurred. By second day, symptoms were resolving but not completely resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, body aches and flu like symptoms were resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661841
Sex: F
Age:
State: NV

Vax Date: 04/01/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Slightly light headed for about 15 minutes.; This is a spontaneous report from a contactable consumer, the patient. A 70-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 01Apr2021 at 12:00 (at the age of 70-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 13:00 (at age of 70-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22Apr2021, after second shot, the patient became slightly light headed for about 15 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event slightly light headed for about 15 minutes was recovered on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661842
Sex: F
Age:
State: MI

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Sharp like needle poking pain in feet/ sore arm; Nausea; Headache; Pain in mouth; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 24Apr2021 at 08:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications included vitamin d nos (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN) and unspecified birth control pill; all taken from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 24Apr2021 at 17:00, the patient experienced sharp like needle poking pain in feet, nausea, headache, sore arm and pain in mouth. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sharp like needle poking pain in feet/ sore arm, nausea, headache and pain in mouth were not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: VITAMIN D NOS; MAGNESIUM

Current Illness:

ID: 1661843
Sex: M
Age:
State: TX

Vax Date: 04/16/2021
Onset Date: 04/20/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: 4 days after vaccine, noticed swelling to lymph node on right clavicle. It is painful to touch.; 4 days after vaccine, noticed swelling to lymph node on right clavicle. It is painful to touch.; Pain radiates up the right side of neck towards the back of right ear; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 16Apr2021 at 11:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 16:00, 4 days after vaccine, the patient experienced swelling to lymph node on right clavicle, it was painful to touch and pain radiated up the right side of neck towards the back of right ear. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling to lymph node on right clavicle, it was painful to touch and pain radiated up the right side of neck towards the back of right ear was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661844
Sex: F
Age:
State: CO

Vax Date: 04/25/2021
Onset Date: 04/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Pain at the shot site; Swelling at the shot site; Headache; Blurred vision; Nausea; metal taste in mouth; Irritability; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 25Apr2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy, and gluten sensitivity. Concomitant medications included fexofenadine hydrochloride (ALLEGRA); taken for unknown indication on an unknown date and unknown if ongoing. The patient previously took morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Apr2021, the patient experienced pain and swelling at the shot site, headache, blurred vision, nausea, metal taste in mouth, irritability and fatigue. It was unknown whether therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of pain and swelling at the shot site, headache, blurred vision, nausea, metal taste in mouth, irritability and fatigue was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FEXOFENADINE HYDROCHLORIDE

Current Illness:

ID: 1661845
Sex: M
Age:
State: CA

Vax Date: 04/20/2021
Onset Date: 04/22/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Tingling, pins and needles in hands and legs; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no other medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 22Apr2021, the patient experienced tingling, pins and needles in hands and legs and was happening all the time. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling, pins and needles in hands and legs was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661846
Sex: F
Age:
State: KS

Vax Date: 04/03/2021
Onset Date: 04/09/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: I smelled and tasted cigarette smoke; I smelled and tasted cigarette smoke; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 09:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 09Apr2021, the patient experienced tasted and smelled cigarette smoke for about 7 full days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events smelled and tasted cigarette smoke was recovered on an unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1661847
Sex: F
Age:
State:

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Ringing ears; Body aches; Shooting pains; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 20Apr2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to mangoes and cashews. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received prednisone (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy. On 20Apr2021 at 22:00, the patient experienced body aches, ringing ears, chills and shooting pains. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events body aches, ringing ears, chills and shooting pains were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661848
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/23/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Swollen lymph node under right armpit; Tender lymph node under right armpit/tenderness has extended into under right arm area; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the right arm on 14Apr2021 at 16:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant past medical history. The patient had no known allergies to medications, food or other products. The patient did not take any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 09:30, 9 days after first dose. the patient experienced swollen and tender lymph node under right armpit (injection site was right arm) and noticed tenderness. On 25Apr2021, the tenderness had extended into under right arm area. The adverse event resulted in emergency room or department or urgent care. No therapeutic measures were taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node under right armpit and tender lymph node under right armpit/tenderness has extended into under right arm area were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661849
Sex: F
Age:
State: CA

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Sore throat; Pain at the injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 12:00 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Apr2021 at 13:00, immediately after vaccination, the patient experienced pain at the injection site. On 20Apr2021, the patient experienced sore throat. On 21Apr2021, the patient's arm felt better but sore throat remained. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain at the injection site was resolving, whereas the event sore throat was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661850
Sex: F
Age: 44
State: FL

Vax Date: 08/17/2021
Onset Date: 08/17/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: None

Allergies: Demerol

Symptom List: Unevaluable event

Symptoms: Arm was sore, but not able tonuse for 3 days. There was no strength for any movement.

Other Meds: None

Current Illness: None

ID: 1661851
Sex: F
Age:
State: VA

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Spotting; heavy flow/menstrual fluid is watered down; heavy flow; This is a spontaneous report from a contactable consumer or other non-HCP (Patient herself). A 29-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0716), dose 1 via an unspecified route of administration, administered in Arm Left on 24Apr2021 15:30 (03:30 pm) (at the age of 29-years-old) (pregnancy at time of vaccination: no) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included prior to vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies and no other medical history. The patient's concomitant medication/medications the patient received within 2 weeks of vaccination included nitrofurantoin (MACROBID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. It was reported that, the last day of the patient's menstrual cycle was 15Apr2021, the day after she received my first round of Pfizer (24Apr2021) on 25Apr2021 07:00, she began spotting. The following day and every day since she has been experiencing a heavy flow. Her menstrual fluid was watered down and very unusual for her. The patient not received treatment for the adverse events. The outcome of the events was not recovered. Follow-up attempts completed. No further information expected.

Other Meds: MACROBID [NITROFURANTOIN]

Current Illness:

ID: 1661852
Sex: F
Age:
State: MD

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:high; Comments: high blood pressure

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Headache; dizziness; High blood pressure; Fever; general body aches; Migraine; extreme fatigue; Diarrhea; Rash on injection site; pain on injection arm; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in Arm Right on 24Apr2021 at 10:00 (Batch/Lot Number: EW0171) as dose 2, single for covid-19 immunization (at the age of 44-years-old). Medical history included asthma, osteoarthritis and covid-19 (prior vaccination) from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via an unspecified route of administration, administered in left arm on 22Mar2021 at 04:00 pm (Batch/Lot Number: EP6958) as single for covid-19 immunization (at the age of 44-years-old). Patient also took morphine and experienced allergy previously. It was reported that within 10 hours after receiving second dose of vaccine on 24Apr2021, the patient experienced fever, general body aches, migraine, extreme fatigue, diarrhea, rash on injection site and pain on injection arm. After 2 days on 26Apr2021 experienced headache, dizziness, diarrhea, and high blood pressure. Patient was treated with Imitrex, Tylenol which mildly helped. Patient was tested COVID post vaccination. The outcome of the events was recovering at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661853
Sex: F
Age:
State: TX

Vax Date: 04/24/2021
Onset Date: 04/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: rash all over my chest and my thigh and my right arm; The doctor said she must be allergic to something in the vaccine.; Red Rash to chest, stomach, sides, right arm; Hard time sleeping; fell asleep with ice pack in her hand; Palms of hands burning like fire; right worse than left; Rash on face; This is a spontaneous report from a contactable consumer (Patient herself). A 28-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Batch/Lot number and Expiration Date was not reported), via an unspecified route of administration, administered in Arm Right on 24Apr2021 (at the age of 28-year-old) as single dose for covid-19 immunization. Medical history included ongoing irritable bowel syndrome (Irritable Bowel Syndrome with Constipation) patient states diagnosed 6 years ago, ongoing gastroesophageal reflux disease (Acid Reflux) patient states diagnosed 6 years ago. The patient did not have any other vaccine prior Vaccinations (within 4 weeks) and none AE(s) following prior vaccinations. History of all previous immunizations with the Pfizer vaccine considered as suspect was none. The patient's concomitant medications were not reported. Patient states she got the first dose of the Covid Vaccine on 24Apr2021. She went to the Emergency Room last night and the doctor there suggested she not take the second dose of the vaccine due to her adverse reaction. It was said that on Sunday morning she noticed she had a rash on her face (On 25Apr2021). And it was not itching or burning. Monday when she got home from work the palms of her hands were burning like fire; the right one worse than the left (On 26Apr2021). There was no redness or swelling. She had a hard time sleeping Monday night and fell asleep with an ice pack in her hand (On 26Apr2021). Yesterday when she got home from her job as a second-grade teacher; she took off her clothes to take a shower. That's when she noticed she had a red rash on her chest, stomach, sides, and her right arm (On 27Apr2021),on an unspecified date she experienced rash all over my chest and my thigh and my right arm. States that she got nervous and called several people. No one would help her without seeing her first. She went to the Emergency Room by her house. The doctor said he didn't recommend getting the second dose of the vaccine due to her reaction from the first dose. The doctor said she must be allergic to something in the vaccine. The Emergency Room doctor gave her a Steroid shot, an epi-pen to take with her just in case symptoms worsened, and also told her to take antihistamines. She was wondering what happens if the vaccine becomes mandatory for work or for travel.States if the doctor told her not to get the second one and asking if she should follow the doctors orders or get the vaccine (27Apr2021). Caller stated the rash on her face and the burning of her palms were gone the day after they started. It was stated the rash to her body had improved and was now barely noticeable. She was concerned because she felt like the symptoms had been changing everyday. The event red rash to chest, stomach, sides, right arm resulted into emergency room. States that when she was a baby she was told she had hives in reaction to the antibiotic Ceclor. Therapeutic measures were taken as a result of rash on face, palms of hands burning like fire; right worse than left, red rash to chest, stomach, sides, right arm, the doctor said she must be allergic to something in the vaccine. The outcome for the events rash on face on 26Apr2021, palms of hands burning like fire; right worse than left was recovered on 27Apr2021, for event , red rash to chest, stomach, sides, right arm was recovering and for other events outcome is unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. Follow-up#1(PRD06May21): This is a follow up-spontaneous report received from a contactable consumer. This consumer (patient) reported in response to non-HCP letter sent to physician via follow-up letter which included that included :Event verbatim rash all over my chest and my thigh and my right arm Coded as Rash. Reporter email address was added. New event was codded. Narrative added with case closure comment. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness: Acid reflux (esophageal) (Verbatim: Acid Reflux States diagnosed 6 years ago.); Irritable bowel syndrome (Verbatim: Irritable Bowel Syndrome with Constipation States diagnosed 6 years ago.)

ID: 1661854
Sex: M
Age:
State:

Vax Date: 03/28/2021
Onset Date: 04/21/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210421; Test Name: oxygen level dropped; Result Unstructured Data: Test Result:decreased

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Oxygen level dropped; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8733), via an unspecified route of administration in arm left on 28Mar2021 as a dose 1, single for COVID-19 immunization. It was reported that, other vaccine same date product included Pfizer (Lot number: ER8729), via an unspecified route of administration in arm left on 28Mar2021 as a dose 2, single. The patient's medical history and concomitant medications were not reported. The patient had no known allergies. No covid prior vaccination and no covid tested post vaccination. On 21Apr2021, the patient experienced oxygen level dropped. The AE resulted in doctor or other healthcare professional office/clinic visit. Treatment included was breathing exercise. On 21Apr2021, the patient underwent lab tests and procedures which included oxygen level dropped (oxygen saturation), resulted as decreased. The outcome of the event was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661855
Sex: F
Age:
State: NY

Vax Date: 03/18/2021
Onset Date: 03/18/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Fast heart rate; Breathing difficulties; Local reaction; This is a spontaneous report from a contactable consumer (patient). A 41-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: En6206), via an unspecified route of administration, administered in Arm Left on 18Mar2021 (at the age of 41-years-old) as dose 1, single for covid-19 immunization at public health clinic/veterans administration facility. Medical history included known allergies to latex, adhesives, buckwheat from an unknown date and unknown if ongoing. The patient previously took lisinopril and motrin [ibuprofen] and experienced allergies. Concomitant medications (other medications in two weeks) included allergy shots. Could contact her for other medical history and for other medications in two weeks. No other vaccine in four weeks. No COVID prior vaccination and no COVID tested post vaccination. On 18Mar2021, after first shot the patient had fast heart rate, breathing difficulties (throughout evening of shot), and local reaction that she still has 6 weeks later with use of topical steroids. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: Er8727) via an unspecified route of administration, administered in Arm Right on 09Apr2021 as dose 2, single for covid-19 immunization. The patient was treated with topical steroid. The outcome of all events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661856
Sex: F
Age:
State: NY

Vax Date: 04/21/2021
Onset Date: 04/23/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe and chronic inflammation in the spine, joints and muscles.; Severe and chronic inflammation in the spine, joints and muscles.; Tingling and numbing sensation from the neck down.; Tingling and numbing sensation from the neck down.; Swelling in the lower legs, ankles and feet; Swelling in the lower legs, ankles and feet; Sciatica in both legs; Left leg calf pain; Loss of appetite; Depression; anxiety; This is a spontaneous report from a non-contactable consumer. This 27-year-old (non-pregnant) female consumer (patient) reported that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EWQ17Q) via an unspecified route of administration into the left arm on 21Apr2021 at 11:15 AM (at the age of 27-year-old) as single dose for COVID-19 immunisation. The patient medical history included lupus-like syndrome from an unknown date and unknown if ongoing. The patient previously took plaquenil [hydroxychloroquine sulfate] and experienced drug hypersensitivity, meloxicam and experienced drug hypersensitivity. Known allergies to Plaquenil and Meloxicam. Concomitant medications were not reported. On 23Apr2021 at around 10:00 AM, the patient experienced severe and chronic inflammation in the spine, joints and muscles, tingling and numbing sensation from the neck down, swelling in the lower legs, ankles and feet, sciatica in both legs, left leg calf pain, loss of appetite, depression and anxiety. No other vaccine in four weeks, no other medications in two weeks. AE resulted in doctor or other healthcare professional office/clinic visit. No treatments, no COVID prior vaccination, no COVID tested post vaccination. Outcome was not resolved for all the events. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661857
Sex: F
Age:
State: CA

Vax Date: 03/23/2021
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: with shortness of breath and pressure on my chest.; with shortness of breath and pressure on my chest.; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 46-years-old female patient received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine, administered via an unspecified route in left arm on 23Mar2021 11:00, at 46 years of age, (Batch/Lot Number: EP6955) as single dose for COVID-19 immunization. Medical history included pernicious anaemia from an unknown date and allergy to sulfa and pethydine hydrochloride (DEMEROL). Concomitant medications included iron, cyanocobalamin (B12-VITAMIN), zinc, folic acid (FOLATE), ascorbic acid (C) and colecalciferol (D), all taken for an unspecified indication since an unknown date. The patient didn't receive any other vaccine within the previous 4 weeks and was not diagnosed with COVID-19 prior vaccination. The patient reported that, on an unknown date after the first vaccine dose, she ended up at hospital with shortness of breath and pressure on her chest. They sent her home after hours of observation saying it was vaccine related symptoms. The events resulted in Emergency room/department or urgent care, the patient received an unspecified treatment and the events resolved with sequelae on an unknown date. No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) :PFIZER INC-2021487210 Same drug/reporter/patient, different dose

Other Meds: IRON; B12-VITAMIIN; ZINC; FOLATE; C; D

Current Illness:

ID: 1661858
Sex: F
Age:
State: CA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210505; Test Name: Fever; Result Unstructured Data: Test Result: 102; Test Date: 20210505; Test Name: Fever; Result Unstructured Data: Test Result: 103.4; Test Date: 20210507; Test Name: Fever; Result Unstructured Data: Test Result: 101; Test Date: 202105; Test Name: Fever; Result Unstructured Data: Test Result: 103.

Allergies:

Symptom List: Nausea

Symptoms: couldn't control any of my muscles; All my muscles, my whole body shaked; fever 103.4; This is a spontaneous report from a contactable other healthcare professional (patient). A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 05May2021 14:15 (lot number and expiry date: unknown) as dose 2, single for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in the Facility. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 14Apr2021 at 13:45 in left arm for COVID-19 immunisation. Concomitant medication included IBUPROFEN taken for an unspecified indication from 03May2021 to an unspecified stop date. On 05May2021, 7-8 hours later than second vaccination, all her muscles shook for at least 2 hours, she couldn't stop shaking, she couldn't control any of the muscles. She also had extreme fever of 103.4. She took Ibuprofen, it decreased to 102. It was day 3 at the time of the report, and she still had fever around 101 after Ibuprofen. Without Ibuprofen, it was still around 103. She didn't inform health providers because she was alone, and she was not able to do anything in that situation. The patient did not receive treatment for the other events. The patient has not been tested for COVID-19 since vaccination. Outcome of the events was recovering. Information on lot/batch number has been requested. Based on the information available a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events neural atrophy. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the product is evaluated as part of procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, as appropriate.

Other Meds: Ibuprofen, Phenylephrine HCl

Current Illness:

ID: 1661859
Sex: F
Age:
State: GA

Vax Date: 04/27/2021
Onset Date: 04/30/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Involuntary movements; Hypnic jerks; Muscle twitching; This is a spontaneous report from a contactable consumer (patient). A 37-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), dose 1 intramuscular, administered in Arm Left on 27Apr2021 11:30 (age at vaccination 37 years) as dose 1, single for covid-19 immunisation. Medical history included anxiety from an unknown date and unknown if ongoing. The patient had no allergies. The patient's concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Apr2021 07:00 the patient experienced hypnic jerks, muscle twitching, involuntary movements on 01May2021. Patient visited physician office for involuntary movements. Patient did not receive any treatment for hypnic jerks and muscle twitching. Patient received treatment for involuntary movements. Also take medication Citalopram anxiety medication. The outcome of events was unknown for involuntary movements rest of events outcome was not recovered. The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1661860
Sex: M
Age:
State: NC

Vax Date: 04/27/2021
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: fever; bodyswell; colds; eyes hurt; sore throat; Sickness; This is a spontaneous report from a Pfizer sponsored program COVAX Support. A male contactable consumer (patient) reported for himself. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on 27Apr2021 (Batch/Lot number was not reported) as Dose 2,Single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. on 2021 The patient second dose 27APR2021 last month. Patient experienced fever, body swell, colds and eyes hurt, sore throat and sickness after his second dose. Caller would like to know if he can take medications or go to Doctor. Outcome of events was unknown. Information on lot/batch number has been requested. Follow-up attempts completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661861
Sex: F
Age:
State: NY

Vax Date: 03/15/2021
Onset Date: 05/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Multiple Palpable lymph nodes New onset Headaches Swelling of extremities/fingers; Multiple Palpable lymph nodes; New onset Headaches; Swelling of extremities/fingers; This is a spontaneous report form a contactable Nurse (patient). A 51-year-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: ER8737), via an unspecified route of administration in arm left on 15Mar2021 (at the age of 51-years-old) as dose 2, single for COVID-19 immunisation. The medical history of the patient included Hashimoto's from an unknown date and unknown if ongoing. The patient had no known allergies. The concomitant medications of the patient included levothyroxine sodium (SYNTHROID) taken for an unspecified indication start and stop date were not reported. It was reported that patient took first dose of BNT162B2(solution for injection, Batch/Lot number: EN6207), via unspecified route of administration on 15Mar2021 at 14:00. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 01May2021, the patient experienced multiple palpable lymph nodes new onset headaches swelling of extremities/fingers, multiple palpable lymph nodes, new onset headaches, swelling of extremities/fingers. The events resulted in the physician office visit. The outcome of the events was reported as not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1661862
Sex: F
Age:
State: CA

Vax Date: 06/02/2021
Onset Date: 06/02/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: felt dizzy; heart beats very strong; This is a spontaneous report from a contactable consumer (caregiver) via Medical Information team. A 50-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration on 02Jun2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on 12May2021 (Batch/Lot number was not reported) for COVID-19 immunisation. On 02Jun2021 (also reported as yesterday), she got the second dose; after that she felt dizzy, like her heart beat very strong. The reporter asked if this was normal. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661863
Sex: F
Age:
State: CO

Vax Date: 04/26/2021
Onset Date: 04/27/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Menstrual bleeding since second dose. Its been more than a month now. And its heavy; This is a spontaneous report from a contactable consumer (patient). A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 26Apr2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. Medical history included none (reported other medical history: no). The patient has no known allergies. The patient was not pregnant at the time of the event. The patient's concomitant medications were not reported. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. The patient did not have COVID prior to vaccination and had not been test for COVID post-vaccination. On 27Apr2021, the patient experienced menstrual bleeding since second dose. According to the patient, it has been more than a month and was heavy. The event resulted in emergency room/department/urgent care visit. Progesterone was received as a treatment for the event. The outcome of the event was not recovered/not resolved. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661864
Sex: F
Age:
State: OH

Vax Date: 06/03/2021
Onset Date: 06/03/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: received the second dose of vaccine 50 days between the first dose; Itchiness on upper extremities; This is a spontaneous report from a contactable consumer (patient). A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Batch/Lot Number, and Expiration Date: Not reported) via an unspecified route of administration in the left arm on 03Jun2021 at 11:00 AM (at the age of 42-year-old) as dose 2, single for COVID-19 immunisation. Medical history was not reported. Concomitant medications included blood pressure and anxiety medications (Unspecified). The patient previously received acetaminophen-codeine (TYLENOL 3) for unknown indication on an unknown date and experienced itch. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Batch/Lot Number, and Expiration Date: Not reported) via an unspecified route of administration in the right arm on 15Apr2021 at 12:45 PM (at the age of 42-year-old) as dose 1, single for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced itchiness on upper extremities on 03Jun2021 and received the second dose of vaccine 50 days between the first dose on 03Jun2021 11:00. Pruritus event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the Pruritus event. The clinical outcome of the Pruritus event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1661865
Sex: F
Age:
State: WA

Vax Date: 05/26/2021
Onset Date: 05/27/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Paresthesia starting in legs 8 hours post vaccine, it has spread to feet, hands, arms, face.; Muscle aches and weakness in legs. Very mild exercise leaves muscles with a dull ache for 8 hours. Legs felt like jelly; Muscle aches and weakness in legs. Very mild exercise leaves muscles with a dull ache for 8 hours. Legs felt like jelly; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/Lot Number: unknown) via an unspecified route of administration in the arm left on 26May2021 at 18:00 (at the age of 36 years old) as dose 1, single dose for COVID-19 immunisation. Medical history included thalassemia minor, minor mitral valve regurgitation and seborrheic dermatitis. Concomitant medications included vitamins. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021 at 02:00 8 hours post vaccine, the patient experienced paresthesia starting in legs, it was spread to feet, hands, arms and face. The patient also had muscle aches and weakness in legs. It was reported that very mild exercise leaved muscles with a dull ache for 8 hours and the legs felt like jelly. The symptoms were not subsided after 8 days. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events muscle aches and weakness in legs, very mild exercise leaves muscles with a dull ache, legs felt like jelly and paresthesia starting in legs, spread to feet, hands, arms, face was not recovered at the time of this report. This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected. The lot number for BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1661866
Sex: F
Age:
State: NC

Vax Date: 03/18/2021
Onset Date: 06/02/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: some really bad shoulder pain and in her right hand; some really bad shoulder pain and in her right hand; some inflammation on the top of one hand; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A 64-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on the left arm on 18Mar2021 (Batch/Lot Number: EN6208) (at age 64-years-old) as dose 2,single for covid-19 immunisation; and tofacitinib citrate (XELJANZ), via an unspecified route of administration from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 5 mg for rheumatoid arthritis. The first dose was received on 25Feb2021 (lot number: EN6203). The patient's medical history and concomitant medications were not reported. Before patient did her second COVID vaccine her rheumatologist suggested she go off the medication for a week. So the night before the second vaccine patient stopped taking tofacitinib and made it a week without it which was difficult when she had been used to taking it, that how much it 'feels'. Patient stated that, so that way she had full effect and have effectiveness of the Pfizer COVID 19 Vaccine, the second one. It worked great and on 02Jun2021, patient had some really bad shoulder pain and in her right hand, and some inflammation on the top of one hand, which was there in morning and evening. It was gone on 03Jun2021, she meant XELJANZ helped so much. When confirmed if the pain was due to the Xeljanz or the COVID 19 Vaccine, patient stated that no, the COVID vaccine she took was way back, and finished the second one like in March. Patient further stated that it was not due to the vaccine. She was telling how much tofacitinib medication helped. She thinks Xeljanz does work for her, she is happy with the medication. Patient was not saying that this shoulder problem had anything to do with the vaccine, her vaccine was given in left arm, the problem that she had for just one day in shoulder was in the right arm. She doesn't think it has to do anything with Pfizer Outcome of the events was recovered on 03Jun2021.Action taken for tofacitinib was unknown. No follow-up attempts are needed. No further information is expected.; Sender's Comments: Based on the available information the reported event is attributed to an underlying or an intercurrent medical condition and it is assessed as unrelated to the suspect drug bnt162b2.

Other Meds:

Current Illness:

ID: 1661867
Sex: M
Age:
State: PA

Vax Date: 04/03/2021
Onset Date: 04/06/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202105; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: I started to get very achy knee joints.; The achy joints progressed to my hands and ankles and feet.; swollen; had difficulty walking and clenching and grasping with my hands; This is a spontaneous report from a contactable consumer. A 63-year-old male consumer received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER8730, Expiration date: unknown) via an unspecified rout in right arm on 03Apr2021 at 07:30 am (at the age of 63-year-old) as dose 2, single for COVID-19 immunisation. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6203, Expiration date: unknown) via an unspecified rout in left arm on 13Mar2021 at 08:30 am (at the age of 63-year-old) as dose 1, single for COVID-19 immunisation. Medical history included Non-Hodgkins Lymphoma. Patient had no known allergies. Concomitant medications were not reported. The patient reported that on 06Apr2021 "3 days following the second Covid 19 vaccine he started to get very achy knee joints. The achy joints progressed to his hands and ankles and feet. The symptoms progressed further and his hands, feet, and ankle became very swollen, very painful and he was unable to wear my regular shoes, and had difficulty walking and clenching and grasping with his hands. My joints are very painful". It was reported that the patient had other medications in two weeks, had not covid prior vaccination, not covid tested post vaccination. Treatment was given with Prednisone since symptoms occurred. Patient underwent laboratory test included Nasal Swab on May2021 resulted Negative. Outcome of the event was not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661868
Sex: U
Age:
State: MD

Vax Date:
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: pain / 3 other patienst complained about the same issue; severe pain in my left ear / 3 other patienst complained about the same issue; This is a spontaneous report from a contactable consumer. This consumer reported for herself and 3 other patients. This is the 3rd of 3 reports. This consumer reported for a patient that: A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced pain / 3 other patients complained about the same issue, severe pain in my left ear / 3 other patients complained about the same issue. Patient reported, she had a physical last Tuesday and her Doctor mentioned to me that 3 other patients complained about the same issue. She saw that hospital were doing research on this, but they would not give her any information. Patient visited physician office for reported events. The outcome of event was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661869
Sex: F
Age:
State: NC

Vax Date:
Onset Date: 02/25/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: A friend had severe masseter muscle tightness to the extent that she could barely open her mouth after both of her vaccines.; This is a spontaneous report from a contactable consumer and reported for a female patient (her friend). A 67-years-old non pregnant female patient received first dose bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Lot Number: EN5318) via an unspecified route of administration on 29Jan2021 in left arm as DOSE 1, SINGLE and also received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot number not reported), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE and also for covid-19 immunization at other vaccine facility. The patient medical history and concomitant medications were not reported. The patient had no known allergies. The patient did not experienced covid prior vaccination and no covid tested post vaccination. The patient did not received other vaccine in four weeks and also no other medications in two weeks. On 25feb2021, the patient had experienced severe masseter muscle tightness to the extent that she could barely open her mouth after administration of 2 dose. It was reported that, patient wondered if more people are reporting this kind of muscle tension and it has been more than 3 months muscle tensions persist. The clinical outcome of the event was unknown. Information about lot/batch number has been requested. Follow-Up (12Jul2021): Follow-up attempts are completed. No further information is expected. Follow-Up (26Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661870
Sex: F
Age:
State: FL

Vax Date: 03/30/2021
Onset Date: 04/01/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Name: Blood test; Result Unstructured Data: Test Result:Normal; Comments: before vaccination; Test Date: 20210401; Test Name: Blood test; Result Unstructured Data: Test Result:Very low blood platelets count; Comments: after vaccination; Test Name: covid test; Result Unstructured Data: Test Result:unknown result; Comments: unknown result, post vaccination

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Not feeling well; Headaches; Dizzy; Big bruises on my body; Very low blood platelets count; This is a spontaneous report from a contactable consumer (Patient). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 30Mar2021 at 17:45 (at the age of 40-year-old), as dose 1, single; and received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: Unknown), via an unspecified route of administration on 20Apr2021 at 17:45 (at the age of 40-year-old), as dose 2, single for COVID-19 immunization at Pharmacy or Drug Store. The patient's medical history and concomitant medications were not reported. Patient did not receive other vaccine in four weeks of COVID vaccine. On 01Apr2021, after receiving the vaccine, the patient was not feeling well, had headaches, and felt dizzy; had big bruises on her body. Doctor did blood test and it showed very low blood platelets count. Patient believed it was related to vaccine as she didn't experience these problems before. Patient's blood platelets count was normal before that. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient did not receive treatment for the adverse events. The patient underwent lab tests and procedures which included SARS-CoV-2 test: unknown result post vaccination on an unspecified date; platelet count: normal before vaccination on an unspecified date; and very low after vaccination on 01Apr2021. The patient had no COVID prior vaccination and was tested COVID post vaccination. The clinical outcome of all the events was not resolved. Information about lot/batch has been requested.

Other Meds:

Current Illness:

ID: 1661871
Sex: F
Age:
State:

Vax Date: 06/01/2021
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Started menstrual cycle 6 days early; Its been 11 days and im still menstruating; This is a spontaneous report from a Non-contactable consumer(herself). A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot Number: EW0191 and expiration date), dose 1 via an unspecified route of administration, administered in Arm Left on 01Jun2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. on an unspecified date. The patient experienced started menstrual cycle 6 days early its been 11 days and I am still menstruating. Outcome of events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661872
Sex: M
Age:
State: WA

Vax Date: 06/11/2021
Onset Date: 06/13/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210613; Test Name: physical exam; Result Unstructured Data: Test Result:left sided forehead and mouth weakness; Comments: His physical exam was notable for left sided forehead and mouth weakness, with loss of left side blink although forced eye closure intact on the left side.

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: developed left side facial weakness and numbness/left sided forehead and mouth weakness; developed left side facial weakness and numbness; loss of left side blink; This is a spontaneous report from a contactable physician.A 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0178 and Expiry date: Unknown), via an dose 2 intramuscular, administered in Arm Right on 11Jun2021 11:15 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine. The patient received other medications of vaccination. The patient was not diagnosed with Covid 19 and has not been tested for Covid-19 Since the vaccination. On 13Jun2021 11:15 the patient experienced developed left side facial weakness and numbness/left sided forehead and mouth weakness, loss of left side blink. The patient underwent lab tests and procedures which included physical examination left sided forehead and mouth weakness on 13Jun2021 His physical exam was notable for left sided forehead and mouth weakness, with loss of left side blink although forced eye closure intact on the left side. The outcome of event was recovering. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1661873
Sex: F
Age:
State:

Vax Date: 06/16/2021
Onset Date: 06/16/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: about an hour after the injection uncontrollable coughing for about 30 min. and heavy sweating. did not do anything different or new after the shot just drove home and walked up 3 flights of stairs as; about an hour after the injection uncontrollable coughing for about 30 min. and heavy sweating. did not do anything different or new after the shot just drove home and walked up 3 flights of stairs as; This is a spontaneous report from a contactable consumer (patient) reported for herself. An 18-years-old (non-pregnant) female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 mRNA Vaccine, Solution for injection, bath/lot number: ew0186), via an unspecified route of administration in left arm on 16Jun2021 at 16:00 (at the age of 18-years-old) as single for COVID-19 immunisation (lot unknown reason: Not available/provided to reporter at the time of report completion). The patient's medical history and concomitant medications were not reported. No covid prior vaccination. The patient was not aware that she had any known allergies. No other vaccine in four weeks. On 16Jun2021, the patient experienced about an hour after the injection uncontrollable coughing for about 30 min. and heavy sweating. did not do anything different or new after the shot just drove home and walked up 3 flights of stairs as usual. No covid tested post vaccination. No treatment received. The outcome of the events was recovered on an unknown date. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1661874
Sex: F
Age:
State: LA

Vax Date:
Onset Date:
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Second dose: Big knot by her neck on top of her shoulder; Second dose: Slight headache; The hurting has gone down from her neck on the side all the way down her arm.; The hurting has gone down from her neck on the side all the way down her arm.; The emergency room doctor thinks she could have nerve damage. She could have this for the rest of her life.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient historical vaccine included bnt162b2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 1, single for Covid-19 immunisation. Patient stated was having some bad side effects from the Pfizer Covid-19 Vaccine. She was calling to see what can be done. She had been to the emergency room. At first, she had a big knot by her neck on top of her shoulder. Usually, she could take Tylenol or Aleve and it would relieve her pain, but now she can barely turn her neck to the left. The hurting had gone down from her neck on the side all the way down her arm. The first shot was not so bad, it was bad for a couple of days and went away. The second one lingered and now nothing will stop it. She went to the emergency room on Sunday, and they gave her a muscle relaxer for pain that was not helping anymore. She kept having a slight headache. She did not have any more questions. She wishes she never took the vaccine. What she can tell about her experience was that it was a bad experience. It did not do her any good to answer questions for a report if she will get no advice on what to do. She did not have these problems before. The emergency room doctor thinks she could have nerve damage. She could have this for the rest of her life. There was nothing anyone can do. She will hurt for the rest of her life behind the crap that Pfizer came out with. She was the one who ended up with medical bills she will have to pay. The events resulted in visit to emergency room visit. The clinical outcome of the events was unknown. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1661875
Sex: F
Age:
State: FL

Vax Date: 07/02/2021
Onset Date: 07/09/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Took the vaccine a week before my period date. My period was delayed. Yesterday I only had 2 spots on my underwear. Today it came a bit more but not like it used too.; This is a spontaneous report from a contactable consumer. A 25-years-old female patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration administered left arm 02Jul2021 20:00 (at the age of 25-years-old) as DOSE 1, SINGLE for Covid-19 immunization. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient previously took aspirin and experienced allergies. On 09Jul2021, the patient experienced took the vaccine a week before my period date. my period was delayed. yesterday I only had 2 spots on my underwear. today it came a bit more but not like it used too. The patient did not received any treatment for the adverse event. The outcome of event was not recovered.

Other Meds:

Current Illness:

ID: 1661876
Sex: F
Age:
State: IN

Vax Date: 04/02/2021
Onset Date: 04/09/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210505; Test Name: Rapid; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Sore arm; stomach cramps; daily diarrhea still 4 months later; This is a spontaneous report from a contactable other health care professional (patient). A 59-year-old nonpregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was unknown) via an unspecified route of administration, administered in Arm Left on 02Apr2021 14:00 (age at vaccination 59-year-old) as single dose for COVID-19 immunisation. Medical history included High blood pressure, degenerative erasure disc disease, arthritis. Patient had no covid prior vaccination. Concomitant medication(s) included lisinopril, pravastatin, hydrocodone all taken for an unspecified indication, start and stop date were not reported. Patient did not receive any prior vaccination in four weeks. Patient had known allergies to penicillin. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was unknown) via an unspecified route of administration, administered in Arm Left on 13Mar2021, 12:00 PM (age at vaccination 59-year-old) as single dose for COVID-19 immunisation. On 09Apr2021 12:00, the patient experienced sore arm, stomach cramps and daily diarrhea still 4 months. AE resulted in physician office visit. The patient received treatment for the events with medication (unspecified). Patient tested covid post vaccination. The patient underwent lab tests and procedures which included rapid test (nasal swab) negative on 05May2021. Outcome of the events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; PRAVASTATIN; HYDROCODONE

Current Illness:

ID: 1661877
Sex: F
Age:
State: FL

Vax Date: 07/02/2021
Onset Date: 07/02/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Fever; headaches; extreme muscle pain and extreme exhaustion; extreme muscle pain and extreme exhaustion; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 52-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported and expiry date: unknown), via an unspecified route of administration, administered in Arm Right on 02Jul2021 at 17:00 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included multiple sclerosis, cardiac failure chronic, drug hypersensitivity (Known allergies: Penicillin). Concomitant medication included paracetamol (TYLENOL). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced fever, headaches and extreme muscle pain and extreme exhaustion on 02Jul2021 at 17:15. No treatment was received for the events. Outcome of the events was not recovered. Information about lot/batch has been requested.

Other Meds: TYLENOL

Current Illness:

ID: 1661878
Sex: F
Age:
State: MD

Vax Date: 07/13/2021
Onset Date: 07/14/2021
Rec V Date: 09/01/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:elevated

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Chest pain; shortness of breath; elevated heart rate; fever; joint pain; muscle pain; This is a spontaneous report from a contactable consumer (patient). A 37-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: not reported, Expiry date: not reported), via an unspecified route of administration in left arm on 13Jul2021 12:00 (at age of 37-years-old) as dose 1, single for covid-19 immunisation. Medical history included allergy to tomatoes, bell peppers, mushrooms, almonds, gluten sensitivity, covid-19. There were no concomitant medications. The patient had not received any other vaccine within 4 weeks. Prior to vaccination, the patient was diagnosed with COVID-19 and post the vaccination, the patient was not tested for COVID-19. On 14Jul2021 11:00, the patient experienced chest pain, shortness of breath, elevated heart rate, fever, joint pain and muscle pain. The patient underwent lab tests and procedures which included heart rate: elevated on an unspecified date. The outcome of the events was unknown. Information about lot/batch number has been requested. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am